Literature DB >> 20929351

Seroprevalence and molecular epidemiology of HTLV-1 isolates from HIV-1 co-infected women in Feira de Santana, Bahia, Brazil.

Filipe Ferreira de Almeida Rego1, Aline Mota-Miranda, Edson de Souza Santos, Bernardo Galvão-Castro, Luiz Carlos Alcantara.   

Abstract

HTLV-1/HIV-1 co-infection is associated with severe clinical manifestations, marked immunodeficiency, and opportunistic pathogenic infections, as well as risk behavior. Salvador, the capital of the State of Bahia, Brazil, has the highest HTLV-1 prevalence (1.74%) found in Brazil. Few studies exist which describe this co-infection found in Salvador and its surrounding areas, much less investigate how these viruses circulate or assess the relationship between them. To describe the epidemiological and molecular features of HTLV in HIV co-infected women. To investigate the prevalence of HTLV/HIV co-infection in surrounding areas, as well as the molecular epidemiology of HTLV, a cross sectional study was carried out involving 107 women infected with HIV-1 from the STD/HIV/AIDS Reference Center located in the neighboring City of Feira de Santana. Patient samples were submitted to ELISA, and HTLV infection was confirmed using Western Blot and Polymerase Chain Reaction (PCR). Phylogenetic analysis using Neighbor-Joining (NJ) and Maximum Likelihood (ML) was performed on HTLV LTR sequences in order to gain further insights about molecular epidemiology and the origins of this virus in Bahia. Four out of five reactive samples were confirmed to be infected with HTLV-1, and one with HTLV-2. The seroprevalence of HTLV among HIV-1 co-infected women was 4.7%. Phylogenetic analysis of the LTR region from four HTLV-1 sequences showed that all isolates were clustered into the main Latin American group within the Transcontinental subgroup of the Cosmopolitan subtype. The HTLV-2 sequence was classified as the HTLV-2c subtype. It was also observed that four HTLV/HIV-1 co-infected women exhibited risk behavior with two having parenteral exposure, while another two were sex workers. This article describes the characteristics of co-infected patients. This co-infection is known to be severe and further studies should be conducted to confirm the suggestion that HTLV-1 is spreading from Salvador to surrounding areas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20929351     DOI: 10.1089/aid.2009.0298

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Phylogenetic and similarity analysis of HTLV-1 isolates from HIV-coinfected patients from the south and southeast regions of Brazil.

Authors:  Mariana Cavalheiro Magri; Luis Fernando de Macedo Brigido; Rosangela Rodrigues; Helena Kaminami Morimoto; João Leandro de Paula Ferreira; Adele Caterino-de-Araujo
Journal:  AIDS Res Hum Retroviruses       Date:  2011-06-24       Impact factor: 2.205

2.  Spread of Human T-Lymphotropic Virus 1 and 2 Among Relatives of People Who Use Illicit Drugs in Northern Brazil.

Authors:  Aldemir Branco Oliveira-Filho; Paula Cristina Rodrigues Frade; Ricardo Roberto de Souza Fonseca; Leila Sawada; Luísa Caricio Martins; Luiz Fernando Almeida Machado; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; José Alexandre Rodrigues de Lemos; Benedikt Fischer; Emil Kupek
Journal:  Front Microbiol       Date:  2022-06-03       Impact factor: 6.064

3.  An overview of sequencing technology platforms applied to HTLV-1 studies: a systematic review.

Authors:  Felipe de Oliveira Andrade; Marina Silveira Cucco; Melina Mosquera Navarro Borba; Reinaldo Conceição Neto; Luana Leandro Gois; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Fernanda Khouri Barreto
Journal:  Arch Virol       Date:  2021-08-20       Impact factor: 2.574

4.  Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-Naïve HIV-1-Infected Individuals in Abuja, Nigeria.

Authors:  Idris Abdullahi Nasir; Abdurrahman Elfulaty Ahmad; Anthony Uchenna Emeribe; Muhammad Sagir Shehu; Jessy Thomas Medugu; Adamu Babayo
Journal:  Virology (Auckl)       Date:  2015-12-14

5.  Distribution of Human Immunodeficiency Virus and Human T-Leukemia Virus Co-infection in Bahia, Brazil.

Authors:  Felicidade Mota Pereira; Fred Luciano Neves Santos; Ângelo Antônio Oliveira Silva; Nathan Menezes Nascimento; Maria da Conceição Chagas Almeida; Roberto Perez Carreiro; Bernardo Galvão-Castro; Maria Fernanda Rios Grassi
Journal:  Front Med (Lausanne)       Date:  2022-01-10

6.  Molecular epidemiology and phylogenetic analysis of human T-lymphotropic virus type 1 in the tax gene and it association with adult t-cell leukemia/lymphoma disorders.

Authors:  Samira Pourrezaei; Shahrzad Shadabi; Maryam Gheidishahran; Abbas Rahimiforoushani; Masoume Akhbari; Mahnaz Tavakoli; Mahshid Safavi; Mobina Madihi; Mehdi Norouzi
Journal:  Iran J Microbiol       Date:  2021-08

7.  Prevalence and genetic characterisation of HTLV-1 and 2 dual infections in patients with pulmonary tuberculosis in Central-West Brazil.

Authors:  Aline Garcia Kozlowski; Megmar Aparecida dos Santos Carneiro; Márcia Alves Dias de Matos; Sheila Araújo Teles; João Alves Filho Araújo; Koko Otsuki; Ana Carolina Paulo Vicente; Regina Maria Bringel Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-10-09       Impact factor: 2.743

8.  SEROPREVALENCE OF HTLV IN A POPULATION OF HIV1-INFECTED PATIENTS IN MIDWESTERN BRAZIL.

Authors:  Aline Garcia Kozlowski; Márcia Alves Dias de Matos; Megmar Aparecida Dos Santos Carneiro; Carmen Luci Rodrigues Lopes; Sheila Araújo Teles; Carolina Paulo Vicente; Regina Maria Bringel Martins
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

9.  Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).

Authors:  Karoline Rodrigues Campos; Maria Gisele Gonçalves; Nadia Aparecida Costa; Adele Caterino-de-Araujo
Journal:  Braz J Infect Dis       Date:  2017-03-24       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.